These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32983669)

  • 41. Impact of different stages of chronic kidney disease on the severity of Willis-Ekbom disease.
    Bhagawati J; Kumar S; Agrawal AK; Acharya S; Wanjari AK; Kamble TK
    J Family Med Prim Care; 2019 Feb; 8(2):432-436. PubMed ID: 30984650
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Review of quality of life instruments for the restless legs syndrome/Willis-Ekbom Disease (RLS/WED): critique and recommendations.
    Walters AS; Frauscher B; Allen R; Benes H; Chaudhuri KR; Garcia-Borreguero D; Lee HB; Picchietti DL; Trenkwalder C; Martinez-Martin P; Stebbins GT; Schrag A;
    J Clin Sleep Med; 2014 Dec; 10(12):1351-7. PubMed ID: 25348243
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnosis, comorbidities, and management of restless legs syndrome.
    Becker PM; Novak M
    Curr Med Res Opin; 2014 Aug; 30(8):1441-60. PubMed ID: 24805265
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Restless legs syndrome.
    Klingelhoefer L; Bhattacharya K; Reichmann H
    Clin Med (Lond); 2016 Aug; 16(4):379-82. PubMed ID: 27481386
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Secondary restless legs syndrome].
    Oka Y; Ioue Y
    Brain Nerve; 2009 May; 61(5):539-47. PubMed ID: 19514514
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Diagnosis and symptom rating scale of restless legs syndrome].
    Inoue Y
    Brain Nerve; 2009 May; 61(5):533-8. PubMed ID: 19514513
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical pharmacology and efficacy of rotigotine (Neupro® patch) in the treatment of restless leg syndrome.
    Ferini-Strambi L; Marelli S; Galbiati A
    Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):967-75. PubMed ID: 27224246
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Restless legs syndrome.
    Ryan M; Slevin JT
    Am J Health Syst Pharm; 2006 Sep; 63(17):1599-612. PubMed ID: 16914630
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Restless arms syndrome: prevalence, impact, and management strategies.
    Ruppert E
    Neuropsychiatr Dis Treat; 2019; 15():1737-1750. PubMed ID: 31308668
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Complementary and alternative therapies for restless legs syndrome: An evidence-based systematic review.
    Xu XM; Liu Y; Jia SY; Dong MX; Cao D; Wei YD
    Sleep Med Rev; 2018 Apr; 38():158-167. PubMed ID: 28886918
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical and biochemical findings in uremic patients with and without restless legs syndrome.
    Collado-Seidel V; Kohnen R; Samtleben W; Hillebrand GF; Oertel WH; Trenkwalder C
    Am J Kidney Dis; 1998 Feb; 31(2):324-8. PubMed ID: 9469505
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical and psychological aspects of restless legs syndrome in uremic patients on hemodialysis.
    Takaki J; Nishi T; Nangaku M; Shimoyama H; Inada T; Matsuyama N; Kumano H; Kuboki T
    Am J Kidney Dis; 2003 Apr; 41(4):833-9. PubMed ID: 12666070
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Depth and Distribution of Symptoms in Restless Legs Syndrome/ Willis-Ekbom Disease.
    Yeh P; Ondo WG; Picchietti DL; Poceta JS; Allen RP; Davies CR; Wang L; Shi Y; Bagai K; Walters AS
    J Clin Sleep Med; 2016 Dec; 12(12):1669-1680. PubMed ID: 27655450
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation.
    Garcia-Borreguero D; Silber MH; Winkelman JW; Högl B; Bainbridge J; Buchfuhrer M; Hadjigeorgiou G; Inoue Y; Manconi M; Oertel W; Ondo W; Winkelmann J; Allen RP
    Sleep Med; 2016 May; 21():1-11. PubMed ID: 27448465
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Non-pharmacological management of periodic limb movements during hemodialysis session in patients with uremic restless legs syndrome.
    Giannaki CD; Sakkas GK; Hadjigeorgiou GM; Karatzaferi C; Patramani G; Lavdas E; Liakopoulos V; Koutedakis Y; Stefanidis I
    ASAIO J; 2010; 56(6):538-42. PubMed ID: 21245801
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of effect of renal transplantation in treatment of restless legs syndrome.
    Azar SA; Hatefi R; Talebi M
    Transplant Proc; 2007 May; 39(4):1132-3. PubMed ID: 17524912
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Restless legs syndrome in women: a review.
    Thomas K; Watson CB
    J Womens Health (Larchmt); 2008 Jun; 17(5):859-68. PubMed ID: 18537487
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Restless leg syndrome in chronic hemodialysis patients in Mashhad hemodialysis centers.
    Zadeh Saraji N; Hami M; Boostani R; Mojahedi MJ
    J Renal Inj Prev; 2017; 6(2):137-141. PubMed ID: 28497091
    [No Abstract]   [Full Text] [Related]  

  • 59. D3 receptor agonist efficacy in restless legs syndrome.
    Casoni F; Galbiati A; Ferini-Strambi L
    Adv Pharmacol; 2019; 84():21-35. PubMed ID: 31229173
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.